Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Enterococcal Bacteremia is Associated with Prolonged Stay in the Medical Intensive Care Unit.

Moses V, Jerobin J, Nair A, Sathyendara S, Balaji V, George IA, Peter JV.

J Glob Infect Dis. 2012 Jan;4(1):26-30. doi: 10.4103/0974-777X.93758.

3.

Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.

Ong DS, Bonten MJ, Safdari K, Spitoni C, Frencken JF, Witteveen E, Horn J, Klein Klouwenberg PM, Cremer OL; MARS consortium.

Clin Infect Dis. 2015 Nov 1;61(9):1413-20. doi: 10.1093/cid/civ560. Epub 2015 Jul 15.

PMID:
26179013
4.

Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.

Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY.

J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.

PMID:
18473099
5.

The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients.

Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB.

Chest. 1999 Apr;115(4):1085-91.

PMID:
10208212
6.

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.

7.

Enterococcal bacteremia in a tertiary care centre in Winnipeg.

Madani TA, Kabani A, Orr P, Nicolle L.

Can J Infect Dis. 1999 Jan;10(1):57-63.

8.

Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens.

McNeeley DF, Saint-Louis F, Noel GJ.

Pediatr Infect Dis J. 1996 Sep;15(9):800-5.

PMID:
8878225
9.

A 25-year study of nosocomial bacteremia in an adult intensive care unit.

Edgeworth JD, Treacher DF, Eykyn SJ.

Crit Care Med. 1999 Aug;27(8):1421-8.

PMID:
10470744
10.

Enterococcal bacteremia in a medical center.

Peng MY, Young TG, Yang CH, Chou MY.

Zhonghua Yi Xue Za Zhi (Taipei). 1994 Nov;54(5):306-11.

PMID:
7834553
11.

Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.

Hamada Y, Magarifuchi H, Oho M, Kusaba K, Nagasawa Z, Fukuoka M, Yamakuchi H, Urakami T, Aoki Y.

J Infect Chemother. 2015 Jul;21(7):527-30. doi: 10.1016/j.jiac.2015.04.001. Epub 2015 Apr 16.

PMID:
25935477
12.

Nosocomial infections in combined medical-surgical intensive care units in the United States.

Richards MJ, Edwards JR, Culver DH, Gaynes RP.

Infect Control Hosp Epidemiol. 2000 Aug;21(8):510-5.

PMID:
10968716
13.

Intensive care unit-acquired bacteremia in mechanically ventilated patients: clinical features and outcomes.

Ko HK, Yu WK, Lien TC, Wang JH, Slutsky AS, Zhang H, Kou YR.

PLoS One. 2013 Dec 23;8(12):e83298. doi: 10.1371/journal.pone.0083298. eCollection 2013.

14.

Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.

Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, Anastassiou ED, Petinaki E, Marangos M, Filos KS, Spiliopoulou I.

Infection. 2014 Dec;42(6):1013-22. doi: 10.1007/s15010-014-0678-1. Epub 2014 Aug 21.

PMID:
25143193
15.

Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.

Aamodt H, Mohn SC, Maselle S, Manji KP, Willems R, Jureen R, Langeland N, Blomberg B.

BMC Infect Dis. 2015 Feb 28;15:107. doi: 10.1186/s12879-015-0845-8.

17.

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR.

Ann Intern Med. 2001 Oct 2;135(7):484-92.

PMID:
11578151
18.

Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.

Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH.

J Antimicrob Chemother. 2006 Apr;57(4):767-70. Epub 2006 Feb 7.

PMID:
16464896
19.

Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.

Song X, Srinivasan A, Plaut D, Perl TM.

Infect Control Hosp Epidemiol. 2003 Apr;24(4):251-6.

PMID:
12725353
20.

[Outbreak of vancomycin-resistant enterococci in a surgical intensive care unit].

Szabó M, Bozó A, Soós S, Darvas K, Harsányi L, Csomós Á.

Orv Hetil. 2015 May 10;156(19):779-84. doi: 10.1556/650.2015.30135. Hungarian.

PMID:
26039917

Supplemental Content

Support Center